VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $304,251,000 | +45.4% | 13,091,646 | -0.4% | 0.05% | +42.9% |
| Q1 2018 | $209,234,000 | +27.7% | 13,142,842 | +66.7% | 0.04% | +29.6% |
| Q4 2017 | $163,855,000 | +514.1% | 7,885,296 | +323.5% | 0.03% | +575.0% |
| Q3 2017 | $26,681,000 | +277.2% | 1,861,855 | +355.3% | 0.00% | +300.0% |
| Q2 2017 | $7,073,000 | -28.4% | 408,910 | -54.3% | 0.00% | -50.0% |
| Q1 2017 | $9,875,000 | -93.5% | 895,244 | -91.4% | 0.00% | -93.8% |
| Q4 2016 | $151,079,000 | -55.1% | 10,404,809 | -24.1% | 0.03% | -56.8% |
| Q3 2016 | $336,638,000 | +25.4% | 13,712,302 | +2.9% | 0.07% | +19.4% |
| Q2 2016 | $268,407,000 | -37.3% | 13,327,115 | -18.1% | 0.06% | -40.4% |
| Q1 2016 | $428,185,000 | -25.8% | 16,280,796 | +186.7% | 0.10% | -24.1% |
| Q4 2015 | $577,181,000 | +63.9% | 5,678,113 | +187.5% | 0.14% | +55.7% |
| Q3 2015 | $352,245,000 | +14.6% | 1,974,686 | +42.8% | 0.09% | -12.0% |
| Q2 2015 | $307,272,000 | -6.8% | 1,383,170 | -16.6% | 0.10% | -9.9% |
| Q1 2015 | $329,542,000 | +82.1% | 1,659,152 | +31.2% | 0.11% | +73.4% |
| Q4 2014 | $180,964,000 | +12.1% | 1,264,503 | +2.8% | 0.06% | +20.8% |
| Q3 2014 | $161,462,000 | +1.1% | 1,230,654 | -2.8% | 0.05% | +6.0% |
| Q2 2014 | $159,761,000 | -10.2% | 1,266,741 | -6.1% | 0.05% | -25.4% |
| Q1 2014 | $177,928,000 | +8.6% | 1,349,680 | -3.3% | 0.07% | +13.6% |
| Q4 2013 | $163,878,000 | +9.0% | 1,395,894 | -3.2% | 0.06% | -3.3% |
| Q3 2013 | $150,415,000 | +29.4% | 1,441,714 | +6.8% | 0.06% | +24.5% |
| Q2 2013 | $116,210,000 | – | 1,350,036 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |